Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mark D. Muttaiah"'
Autor:
Anand V. Kulkarni, Harshvardhan Tevethia, Karan Kumar, Madhumita Premkumar, Mark D. Muttaiah, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Satoru Kakizaki, Arndt Vogel, Richard S. Finn, Padaki Nagaraja Rao, Anjana Pillai, Duvvur Nageshwar Reddy, Amit G. Singal
Publikováno v:
EClinicalMedicine, Vol 63, Iss , Pp 102179- (2023)
Summary: Background: Atezolizumab-bevacizumab (atezo-bev) is recommended as first-line therapy for patients with unresectable hepatocellular carcinoma (uHCC). However, its effectiveness and safety in other populations, including those with Child-Turc
Externí odkaz:
https://doaj.org/article/ea732d774da342e591c1f6808e94fa44
